Corteva tumbles 56.6% as U.S. stock futures trade mixed

  • Corteva led premarket decliners, while Progress Software shares also fell after quarterly results.
  • 56.6% was Corteva's premarket decline to $33.89 on Thursday.
  • Liquidia cited a Delaware ruling involving United Therapeutics patents and Yutrepia.

U.S. stock futures were mixed Thursday morning, with Dow futures down around 200 points. Corteva shares led premarket decliners, falling 56.6% to $33.89, while Nft Ltd dropped 54.6% to $0.98 after announcing a $36 million offering of 80 million shares at $0.45 each. Progress Software fell 2.3% to $39.05 after reporting fiscal third-quarter revenue of $246 million, down 2% year over year; non-GAAP EPS rose 13% to $1.69 and ARR, or annual recurring revenue, increased 1% to $873 million. Other decliners included Vivakor, Lion Group Holding, Inventiva, SGHC, Waterdrop, Paysign, Liquidia and Pacific Biosciences. Liquidia's decline followed a Delaware federal court ruling that two patent claims asserted by United Therapeutics were valid and infringed, in litigation involving Yutrepia, Liquidia's lead product. Lion Group had recently announced a strategic reallocation of part of its digital-asset treasury, while its shares had gained more than 25% Wednesday.

本网站上的信息是使用AI生成的,我们无法保证其准确性。 请仅作为参考信息使用。